Skip to content
Vectorb2b
  • Home
  • About us
    • Governance
    • Our team
    • Careers
  • Services
    • Discovery
    • Toxicology
    • Chemistry Manufacturing
    • Clinical Services
    • Functional Service Providing
    • R&D Portfolio Management Services
    • Integrated Solutions
  • Articles
  • News
  • Contacts
  • Home
  • About us
    • Governance
    • Our team
    • Careers
  • Services
    • Discovery
    • Toxicology
    • Chemistry Manufacturing
    • Clinical Services
    • Functional Service Providing
    • R&D Portfolio Management Services
    • Integrated Solutions
  • Articles
  • News
  • Contacts
VectorB2B
  • May 26, 2026

In vivo phage display: advancing antibody selection for targeted drug development

  • April 27, 2026

In vivo models in retinal research: bridging pathophysiology and translational development

  • April 17, 2026

Outsourcing de investigação clínica: superar constrangimentos operacionais no contexto hospitalar

How can in vivo phage display support antibody selection and targeted drug development?

In vivo phage display: advancing antibody selection for targeted drug development

May 26, 2026
Read More »
How do in vivo models in retinal research bridge pathophysiology and translational development?

In vivo models in retinal research: bridging pathophysiology and translational development

April 27, 2026
Read More »
How can clinical trial outsourcing overcome operational bottlenecks in hospital-based research?

Outsourcing de investigação clínica: superar constrangimentos operacionais no contexto hospitalar

April 17, 2026
Read More »
How can clinical trial outsourcing overcome operational bottlenecks in hospital-based research?

Clinical trial outsourcing: overcoming operational bottlenecks in hospital-based research

April 17, 2026
Read More »
The role of CROs in clinical research: from operational management to regulatory-compliant study execution

The role of CROs in clinical research: why specialised execution matters

March 31, 2026
Read More »
The principles and applications of xenograft models in preclinical oncology research

Xenograft models in cancer research: principles and applications in preclinical oncology

March 26, 2026
Read More »
Load More
Vector B2B

Follow Us

Quick access
  • Discovery
  • Toxicology
  • Manufacturing Services
  • Clinical Services
  • Integrated Solutions
  • Careers
Contacts

Avenida da Liberdade, 258, 6.º 1250-149 Lisboa Portugal

+351 210 976 863

info@vectorb2b.com

  • Copyright © 2026
  • All rights reserved
  • Privacy policy